LINCOLNSHIRE, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ALZHEIMER'S DISEASE INTERNATIONAL C/O WIPFLI LLP, founded in 1985, is a community nonprofit that reported $1.9M in total revenue in fiscal year 2024. Revenue decreased 15% compared to the prior year. Expenses of $2.3M exceeded revenue, resulting in a 23% operating deficit.
ADI'S VISION IS RISK REDUCTION, TIMELY DIAGNOSIS, CARE AND INCLUSION TODAY, AND CURE TOMORROW. ADI'S MISSION IS TO STRENGTHEN AND SUPPORT ALZHEIMER AND DEMENTIA ASSOCIATIONS, TO RAISE AWARENESS AND LOWER STIGMA ABOUT DEMENTIA WORLDWIDE, TO MAKE DEMENTIA A GLOBAL HEALTH PRIORITY, TO SUPPORT AND EMPOWER PEOPLE LIVING WITH DEMENTIA AND THEIR CARE PARTNERS, AND TO INCREASE INVESTMENT AND INNOVATION IN DEMENTIA RESEARCH.
WORLD ALZHEIMER'S MONTH 2024 SAW 111 COUNTRIES PARTICIPATING, 35 MILLION SOCIAL MEDIA IMPRESSIONS OF THE HASHTAGS AND 300 PIECES OF TRADITIONAL MEDIA COVERAGE. ADI WAS PLEASED TO WELCOME ITS SECOND...
WORLD ALZHEIMER'S MONTH 2024 SAW 111 COUNTRIES PARTICIPATING, 35 MILLION SOCIAL MEDIA IMPRESSIONS OF THE HASHTAGS AND 300 PIECES OF TRADITIONAL MEDIA COVERAGE. ADI WAS PLEASED TO WELCOME ITS SECOND COHORT OF 6 DIGITAL INTERNS TO PARTICIPATE IN THE CAMPAIGN.
A THREE-DAY ALZHEIMER UNIVERSITY WAS HELD IN APRIL 2025 IN LONDON. MEMBER WEBINARS AND ONLINE MEETINGS WERE HELD DURING THE YEAR WITH PARTICIPANTS FROM COUNTRIES, INCLUDING SESSIONS TARGETED FOR...
A THREE-DAY ALZHEIMER UNIVERSITY WAS HELD IN APRIL 2025 IN LONDON. MEMBER WEBINARS AND ONLINE MEETINGS WERE HELD DURING THE YEAR WITH PARTICIPANTS FROM COUNTRIES, INCLUDING SESSIONS TARGETED FOR MEMBERS IN THE CARIBBEAN, LATIN AMERICA AND AFRICA.
ADI CONTINUED TO PARTICIPATE IN RESEARCH PROJECTS AND COLLABORATIONS, INCLUDING A MEMORANDUM OF UNDERSTANDING WITH THE WORLD-WIDE FINGERS PROJECT, FORMING CONNECTIONS BETWEEN GLOBAL BRAIN HEALTH...
ADI CONTINUED TO PARTICIPATE IN RESEARCH PROJECTS AND COLLABORATIONS, INCLUDING A MEMORANDUM OF UNDERSTANDING WITH THE WORLD-WIDE FINGERS PROJECT, FORMING CONNECTIONS BETWEEN GLOBAL BRAIN HEALTH INSTITUTE (GBHI) FELLOWS AND ADI MEMBERS. ADI WORKED WITH LONDON SCHOOL OF ECONOMICS (LSE) AND LORENZO'S HOUSE TO ADAPT THE EVIDENCE-BASED STRIDE ANTI-STIGMA TOOLKIT TO ADDRESS THE UNIQUE NEEDS OF YOUNG PEOPLE COPING WITH A PARENT WITH YOUNGER-ONSET DEMENTIA. ADI COLLABORATED IN OTHER RESEARCH PROJECTS AND PHARMACEUTICAL COMPANY INITIATIVES TO PROMOTE THE INVOLVEMENT OF ALZHEIMER ASSOCIATIONS, PARTICULARLY FROM LOW AND MIDDLE INCOME COUNTRIES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,904,247 | $2,248,135 | -0.2% |
| Expenses | $2,343,364 | $2,760,043 | -0.2% |
| Net Income | $-439,117 | $-511,908 | -0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PAOLA BARBARINO | CEO | 48.00 |
Officer
Director
|
$189,530 | $20,172 | $209,702 |
| DALE GOLDHAWK | CHAIR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| RICHARD DAVIES | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| ALIREZA ATRI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PAUL ATTEA | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| MAREE MCCABE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| EMILY ONG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MEERA PATTABIRAMAN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JESUS RODRIGO RAMOS | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ROSA FARRES GONZALEZ SARAVIA | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| AMEENAH SOREFAN | DIRECTOR | 6.00 |
Director
|
$0 | $0 | $0 |
| HUALI WANG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NIGEL JENNER | FINANCE DIRECTOR | 40.00 |
Officer
|
$113,284 | $7,451 | $120,735 |
| CHRISTOPHER LYNCH | DEPUTY CEO | 40.00 |
Highest
|
$116,130 | $8,945 | $125,075 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,904,247 | $2,343,364 | $716,289 | $-439,117 |
| 2024 | No data | No data | No data | No data |
| 2023 | $1,684,339 | $1,868,319 | $1,648,104 | $-183,980 |
| 2022 | $1,487,025 | $1,646,416 | $1,542,318 | $-159,391 |
| 2022 | $2,118,188 | $2,045,192 | $1,870,718 | $72,996 |
| 2021 | $2,451,639 | $2,076,849 | $1,595,029 | $374,790 |
| 2020 | $1,941,346 | $1,471,497 | $1,982,163 | $469,849 |
| 2019 | $1,993,799 | $1,944,827 | $790,608 | $48,972 |
| 2018 | $1,447,143 | $1,270,023 | $1,125,969 | $177,120 |
Compare ALZHEIMER'S DISEASE INTERNATIONAL C/O WIPFLI LLP with other nonprofits in Illinois and across the country.